Journal of Medical Genetics · 2003 · 46 citations · 19 references
MedicineGeneticsMolecular GeneticsCancer GeneticsGastrointestinal OncologyMolecular OncologyCancer Cell SignalingGastric CancerMalignant NeoplasmsDiffuse-type Gastric CancerFamilial Gastric CancerGastric Cancer GeneticsGastric PathologyMet Receptor Tyrosine KinaseOncogenic Receptor Tyrosine Kinase Mutations
astric cancer is one of the most deadly cancers world wide. Although its incidence has declined in recent years, it is still the most prevalent cancer in Asian countries such as Korea and Japan. 1 Germline mutations of the cell to cell adhesion molecule E-cadherin (CDH1) have been reported in patients with the diffuse type of familial gastric cancer. 2 3 However, the frequency of CDH1 mutations is low overall 4 and the observed mutations differ between western and Asian patients. Truncating mutations (that is, nonsense, frameshift, and alternative splicing mutations) predominate in patients of western origin, 2 3 whereas only a few missense mutations have been found in patients of Asian extraction. 5 6 This suggested that CDH1 does not play a major role in gastric cancer development in Asian countries, and prompted researchers to investigate other gastric cancer causing genes.
19
E-cadherin germline mutations in familial gastric cancer
Parry Guilford, Justin Hopkins, James Harraway et al. · Nature · 1998 · 1.7K citations
Familial gastric cancer: overview and guidelines for management.
Carlos Caldas, Fátima Carneiro, Henry T. Lynch et al. · PubMed · 1999 · 509 citations
Life Sciences, Genetics, Oncology +17
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Laura S. Schmidt, Kerstin Junker, Noboru Nakaigawa et al. · Oncogene · 1999 · 505 citations